Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review

Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review

A 72-year-old female and a 57-year-old male with chronic hepatitis C were treated with a combination therapy of pegylated interferon (PEG-IFN)-α 2a (180 µg s.c. once a week) and ribavirin (1,000 mg orally daily). This resulted in the destruction of melanocytes at the injection site in both patients....

Full description

Bibliographic Details
Main Authors: V. Arya, M. Bansal, L. Girard, S. Arya, A. Valluri
Format: Article
Language:English
Published: Karger Publishers 2010-08-01
Series:Case Reports in Dermatology
Subjects:
Vitiligo
Injection site
PEG-IFN-α 2a
Chronic hepatitis C
Online Access:http://www.karger.com/Article/FullText/320207

Similar Items

Similar Items